Skip to Main Content

For further information, see CMDT Part 15-37: Amyloidosis

KEY FEATURES

  • Congo red positive amyloid protein on tissue biopsy

  • Primary amyloid protein is kappa or lambda immunoglobulin light chain

  • In primary amyloidosis, there is usually a serum or urine (or both) light chain paraprotein

General Considerations

  • A rare condition whereby

    • A protein abnormally deposits in tissue

    • Results in organ dysfunction

  • There are six main categories, classified according to the type of amyloid protein deposited

    • Primary (immunoglobulin light chain [AL])

    • Secondary

      • Serum protein A

      • Produced in chronic inflammatory conditions [AA]

    • Hereditary (mutated transthyretin [TTR])

    • Senile

      • Wild-type TTR

      • Atrial natriuretic peptide

    • Dialysis-related

      • β2-microglobulin

      • Not filtered out by dialysis membranes [Aβ2M]

    • LECT2 (associated with Latina/Latino patients)

  • Amyloidosis is further classified as

    • Localized (amyloid deposits only in a single tissue type or organ)

    • Systemic (widespread amyloid deposition)

CLINICAL FINDINGS

Symptoms and Signs

  • Localized amyloidosis: symptoms and signs are related to the affected single organ, such as

    • Hoarseness (vocal folds)

    • Proptosis and visual disturbance (orbits)

  • Systemic amyloidosis: symptoms and signs of unexplained medical syndromes, including

    • Heart failure (infiltrative/restrictive cardiomyopathy)

    • Nephrotic syndrome

    • Malabsorption and weight loss

    • Hepatic dysfunction

    • Autonomic insufficiency

    • Carpal tunnel syndrome (often bilateral)

    • Sensorimotor peripheral neuropathy

  • Additional signs and symptoms include

    • Enlarged tongue

    • Waxy, rough plaques on skin

    • Contusions (including the periorbital areas)

    • Cough or dyspnea

    • Disturbed deglutition

Differential Diagnosis

  • Plasma cell myeloma

  • Monoclonal gammopathy of unknown significance (MGUS)

  • Other malignant lymphoproliferative disorders with a paraprotein

DIAGNOSIS

Laboratory Tests

  • In primary AL amyloidosis

    • Serum and urine will reveal

      • Kappa or lambda light chain paraprotein by protein electrophoresis (PEP), immunofixation electrophoresis (IFE), or free light chain assay (90% of patients)

    • Mass spectroscopy demonstrates light chain in the tissue biopsy in remainder of patients

  • Albuminuria is present with renal amyloid; can be in the nephrotic range

Diagnostic Procedures

  • Cardiac amyloidosis

    • Echocardiogram

      • Infiltrative cardiomyopathy with thick ventricular walls

      • Specific speckling pattern may be seen

    • ECG: low QRS voltages

    • Cardiac MRI

      • Has a distinctive delayed enhancement of gadolinium

      • Virtually diagnostic

  • Blind aspiration of the abdominal fat pad

    • Reveals systemic amyloid two-thirds of the time

    • If unrevealing, then the affected organ needs biopsy

  • Tissue biopsy

    • Required to diagnose amyloid protein

    • Demonstrates deposition of a pink interstitial substance in the tissue with the hematoxylin and eosin stain

    • Protein stains red with Congo red

    • Becomes an apple-green color when the light is polarized

  • Electron microscopy

    • Amyloid fibrils form beta-pleated sheets

    • Amyloid protein is either the kappa or lambda immunoglobulin light chain

  • Bone marrow examination

    • In primary amyloidosis, most have a small excess of kappa- or lambda-restricted plasma cells (but < 10%)

    • May or may not demonstrate interstitial amyloid deposition or amyloid in the blood vessels

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

  • Create a Free Profile